- Home
- CVM vs YSXT Comparison
CVM vs YSXT Comparison
Compare CVM & YSXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CVM | YSXT |
|---|---|---|
| Founded | 1983 | 2011 |
| Country | United States | China |
| Employees | N/A | 39 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Automotive Aftermarket |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.4M | 33.5M |
| IPO Year | 1996 | N/A |
Fundamental Metrics
Financial Performance| Metric | CVM | YSXT |
|---|---|---|
| Price | $4.36 | $1.24 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 38.0K | ★ 197.9K |
| Earning Date | 05-14-2026 | 02-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $264,033.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $5.57 |
| Revenue Growth | ★ 65.45 | N/A |
| 52 Week Low | $0.23 | $1.03 |
| 52 Week High | $13.48 | $9.90 |
Technical Indicators
Market Signals| Indicator | CVM | YSXT |
|---|---|---|
| Relative Strength Index (RSI) | 56.74 | 50.10 |
| Support Level | $4.01 | $1.08 |
| Resistance Level | $4.73 | $1.47 |
| Average True Range (ATR) | 0.38 | 0.09 |
| MACD | 0.12 | -0.00 |
| Stochastic Oscillator | 70.93 | 77.72 |
Price Performance
Historical ComparisonAbout CVM Cel-Sci Corporation
CEL-SCI Corp is a late clinical-stage biotechnology company dedicated to research and development directed at improving the treatment of cancer and other diseases by using the immune system, the body's natural defense system. The company is focused on the development of the following product candidates and technologies: 1) Multikine, an investigational Phase 3 immunotherapy under development for the potential treatment of certain head and neck cancers; 2) LEAPS (Ligand Epitope Antigen Presentation System) technology, for the potential treatment of rheumatoid arthritis.
About YSXT YSX Tech. Co. Ltd Class A Ordinary Shares
YSX Tech Co Ltd provide business solutions to enterprise customers, mainly insurance companies and brokerages, in China. The company has three operating segments: Auto Insurance Aftermarket Value-added Services, Other Scenario-based Customized Services and Software Development and Information Technology Services. Key revenue is generated from Auto Insurance Aftermarket Value-added Services segment which include four types value added services: vehicle safety inspection and check services, vehicle driving risk screening services, designated driver and rescue services and vehicle maintenance and other value-added services.